KRAS and lung carcinoma: The role of KRAS mutations and their potential association with other common genetic lung cancer lesions (LKB1, TP53) has recently been investigated in different cohorts of human lung adenocarcinomas using transcriptional, mutational, copy-number and proteomic data.